
Indian Patent Office: Grants Patil In-Vivo Power Generator Patent After IIT Dispute
Summary
- Dr. Tarkeshwar Chandrakant Patil secured a patent for an in-vivo power generator after a decade-long dispute.
- The invention generates electricity inside the human body to power medical implants, using glucose from cerebrospinal fluid.
- IIT Bombay initially filed the patent in 2013 but assigned all intellectual property rights to Patil in 2017.
- Despite the assignment, IIT Bombay contested Patil's rights in India, leading to a prolonged delay.
- The Bombay High Court intervened, criticizing IIT Bombay and ordering Patil's recognition as the original inventor.
Breakthrough in Medical Implant Power
The Bombay High Court, in its September 8 order, sharply criticized IIT Bombay's actions, characterizing them as the "systematic frustration of a premier scientist."
The Indian Patent Office has formally granted a patent to Dr. Tarkeshwar Chandrakant Patil for his innovative in-vivo power generator. This significant development follows a protracted, decade-long legal dispute with the Indian Institute of Technology (IIT) Bombay, culminating in a favorable order from the Bombay High Court. The patent secures Dr. Patil's exclusive rights to a technology designed to generate electrical power directly within the human body, specifically for powering medical implants.
Dr. Patil's patented device represents a substantial advancement in medical technology. It operates by converting glucose, readily available in cerebrospinal fluid, into a hydrogen-rich fuel such as ethanol or methanol, utilizing specialized bioenzymes. This fuel then powers a nano-scale biofuel cell implanted within the body, creating a self-sustaining energy source. The primary benefit of this invention is its potential to eliminate the need for repeated surgical procedures, which are currently required to replace traditional lithium-ion button batteries in medical implants.
A Decade-Long Intellectual Property Struggle
The journey to patent approval for this groundbreaking medical implant power technology was fraught with challenges, primarily stemming from a prolonged dispute with IIT Bombay. The institution initially filed the patent application in August 2013. However, following internal disagreements, IIT Bombay executed a worldwide assignment deed in 2017, which explicitly transferred all intellectual property rights related to the invention to Dr. Patil.
Despite this formal transfer of ownership, IIT Bombay subsequently contested Dr. Patil's rights within India. This unexpected challenge from the institution led to a significant and prolonged delay in Dr. Patil's ability to secure the patent for his own invention, extending the dispute for many years after the assignment deed was signed.
Judicial Intervention and Inventor Recognition
The impasse was ultimately resolved through the intervention of the Bombay High Court. In a decisive order issued on September 8, the court addressed the long-standing dispute, critically assessing IIT Bombay's actions. The High Court characterized the institution's conduct as the "systematic frustration of a premier scientist," highlighting the undue obstacles placed before Dr. Patil.
The court's ruling was unequivocal: it declared Dr. Patil as the original inventor of the patent. Furthermore, the Bombay High Court directed a Deputy Controller of Patents and Designs to formally recognize Dr. Patil in this capacity. This judicial mandate paved the way for the Indian Patent Office to finally approve the patent, acknowledging Dr. Patil's rightful ownership and inventorship after years of contention.
Protecting Inventor Rights Post-Assignment
This case underscores the critical importance of robust and unambiguous intellectual property assignment deeds, particularly in academic and research environments. Even with a worldwide assignment deed explicitly transferring all rights, Dr. Patil faced significant institutional resistance, highlighting potential vulnerabilities for inventors when institutions contest previously agreed-upon terms. The dispute illustrates that formal documentation alone may not always prevent challenges to inventor rights, necessitating judicial intervention to enforce such agreements.
The outcome of this case serves as a crucial reminder for both inventors and institutions regarding the sanctity of intellectual property transfers. It emphasizes the need for clear, legally sound processes for recognizing and protecting the contributions of individual scientists, ensuring that their inventorship is acknowledged and their rights are upheld, even when facing opposition from powerful entities like academic institutions.
Practical Implications
This case highlights the critical importance of clear intellectual property assignment deeds and the potential for prolonged disputes over inventor rights, even after formal transfers. Lawyers should advise clients on ensuring robust documentation and be prepared for judicial intervention to enforce inventor recognition against institutional resistance, particularly in the context of academic or research collaborations.
Source
How does this affect you?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.
Wansom is AI and can make mistakes.
